These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 136606)

  • 1. Use of peritoneoscopy for initial staging and posttherapy evaluation of patients with ovarian carcinoma.
    Rosenoff SH; Young RC; Chabner B; Hubbard S; De Vita VT; Schein PS
    Natl Cancer Inst Monogr; 1975 Oct; 42():81-6. PubMed ID: 136606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneoscopy: a valuable staging tool in ovarian carcinoma.
    Rosenoff SH; Young RC; Anderson T; Bagley C; Chabner B; Schein PS; Hubbard S; DeVita VT
    Ann Intern Med; 1975 Jul; 83(1):37-41. PubMed ID: 125057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ovarian carcinoma: current therapeutic aspects. A review].
    Buser K; Hänggi W; Greiner R; Schatzmann E
    Schweiz Med Wochenschr; 1990 Nov; 120(44):1617-32. PubMed ID: 2251477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
    Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ; Lele SB
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-look laparoscopy prior to proposed second-look laparotomy.
    Piver MS; Lele SB; Barlow JJ; Gamarra M
    Obstet Gynecol; 1980 May; 55(5):571-3. PubMed ID: 6445047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneoscopy: a technique to evaluate therapeutic efficacy in non-Hodgkin's lymphoma patients.
    Anderson T; Bender RA; Rosenoff SH; Brereton HD; Chabner BA; DeVita VT; Hubbard SP; Young RC
    Cancer Treat Rep; 1977 Sep; 61(6):1017-22. PubMed ID: 143345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiotherapy after chemotherapy and second-look laparotomy in the treatment of advanced ovarian cancers].
    Chauvet B; Fignon A; Lansac J; Calais G; Le Floch O
    Ann Radiol (Paris); 1989; 32(2):131-5. PubMed ID: 2667432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of second-look laparotomy in patients with early-stage ovarian carcinoma.
    Walton L; Ellenberg SS; Major F; Miller A; Park R; Young RC
    Obstet Gynecol; 1987 Nov; 70(5):770-3. PubMed ID: 3658289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
    Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
    Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors].
    Ferrero JM; Largillier R; Ramaioli A; Heudier P; Teissier E; Namer M
    Bull Cancer; 1997 Jul; 84(7):722-8. PubMed ID: 9339198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
    Del Campo JM; Felip E; Rubio D; Vidal R; Bermejo B; Colomer R; Zanon V
    Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Irradiation in the treatment of adenocarcinoma of the ovary. Retrospective study of 44 cases].
    Chauvet B; Fignon A; Calais G; Lansac J; le Floch O
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(4):526-32. PubMed ID: 2778290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
    Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
    Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laparoscopy as part of the evaluation and management of ovarian and cervix neoplasms].
    Ben David Y; Bustan M; Shalev E
    Harefuah; 2001 Jun; 140(6):464-7, 568. PubMed ID: 11420840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneoscopy in the management of ovarian cancer.
    Ozols RF; Fisher RI; Anderson T; Makuch R; Young RC
    Am J Obstet Gynecol; 1981 Jul; 140(6):611-9. PubMed ID: 6455064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gynecological malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic surgical staging of ovarian cancer.
    Childers JM; Lang J; Surwit EA; Hatch KD
    Gynecol Oncol; 1995 Oct; 59(1):25-33. PubMed ID: 7557611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.